Investigation of neutralization, kinetics and stability of Chironex fleckeri antivenom, the lethal box jellyfish.
Summary
C. fleckeri envenomings have a direct impact on Far North Queensland communities public health, recreation, and tourism. The primary treatments for C. fleckeri envenomation is opioids and antivenom (Queensland Health). Treatment with antivenom would hopefully prevent effects seen in severe envenomation by neutralizing causative toxins in the venom. The Common Serum Laboratories (CSL) produce the antivenom, but its efficacy has been called into question by the research and medical community. Furthermore, it was reported in multiple clinical cases to be of little therapeutic benefit, with fatalities even after antivenom administration.
Principal Investigator